Stock Events

Stock Events

Damora Therapeutics (DMRA) Q2 2026 Earnings

12MayConfirmed

Q4 2025

Q2 2026

-2.36

-1.7

-1.05

-0.39

Details

Expected EPS

-0.387767

Actual EPS

-0.62

Surprise EPS

-0.23

Surprise Percent

+59.89%

Description

Damora Therapeutics (DMRA) has reported earnings of -0.62 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.